ArticleSpringer seminars in immunopathology2006

Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.

Thomas F Tedder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.